Department of Molecular Genetics and Microbiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131-0001, USA.
BMC Cancer. 2011 Jan 25;11:30. doi: 10.1186/1471-2407-11-30.
The c-Myb transcription factor regulates differentiation and proliferation in hematopoietic cells, stem cells and epithelial cells. Although oncogenic versions of c-Myb were first associated with leukemias, over expression or rearrangement of the c-myb gene is common in several types of solid tumors, including breast cancers. Expression of the c-myb gene in human breast cancer cells is dependent on estrogen stimulation, but little is known about the activities of the c-Myb protein or what genes it regulates in estrogen-stimulated cells.
We used chromatin immunoprecipitation coupled with whole genome promoter tiling microarrays to identify endogenous c-Myb target genes in human MCF-7 breast cancer cells and characterized the activity of c-Myb at a panel of target genes during different stages of estrogen deprivation and stimulation.
By using different antibodies and different growth conditions, the c-Myb protein was found associated with over 10,000 promoters in MCF-7 cells, including many genes that encode cell cycle regulators or transcription factors and more than 60 genes that encode microRNAs. Several previously identified c-Myb target genes were identified, including CCNB1, MYC and CXCR4 and novel targets such as JUN, KLF4, NANOG and SND1. By studying a panel of these targets to validate the results, we found that estradiol stimulation triggered the association of c-Myb with promoters and that association correlated with increased target gene expression. We studied one target gene, CXCR4, in detail, showing that c-Myb associated with the CXCR4 gene promoter and activated a CXCR4 reporter gene in transfection assays.
Our results show that c-Myb associates with a surprisingly large number of promoters in human cells. The results also suggest that estradiol stimulation leads to large-scale, genome-wide changes in c-Myb activity and subsequent changes in gene expression in human breast cancer cells.
c-Myb 转录因子调节造血细胞、干细胞和上皮细胞的分化和增殖。虽然最初与白血病相关的 c-Myb 致癌版本,但 c-myb 基因的过度表达或重排在几种实体肿瘤中很常见,包括乳腺癌。人乳腺癌细胞中 c-myb 基因的表达依赖于雌激素刺激,但对 c-Myb 蛋白的活性或它在雌激素刺激细胞中调节的基因知之甚少。
我们使用染色质免疫沉淀结合全基因组启动子平铺微阵列来鉴定人 MCF-7 乳腺癌细胞中内源性 c-Myb 靶基因,并在雌激素剥夺和刺激的不同阶段表征 c-Myb 在一组靶基因上的活性。
使用不同的抗体和不同的生长条件,在 MCF-7 细胞中发现 c-Myb 蛋白与超过 10000 个启动子相关,包括许多编码细胞周期调节剂或转录因子的基因和超过 60 个编码 microRNAs 的基因。鉴定了几个先前鉴定的 c-Myb 靶基因,包括 CCNB1、MYC 和 CXCR4 以及新的靶基因,如 JUN、KLF4、NANOG 和 SND1。通过研究这些靶基因的一个面板来验证结果,我们发现雌二醇刺激触发了 c-Myb 与启动子的结合,并且这种结合与靶基因表达的增加相关。我们详细研究了一个靶基因 CXCR4,表明 c-Myb 与 CXCR4 基因启动子结合,并在转染实验中激活了 CXCR4 报告基因。
我们的结果表明,c-Myb 在人类细胞中与大量启动子相关。结果还表明,雌二醇刺激导致 c-Myb 活性的大规模全基因组变化,随后导致人乳腺癌细胞中基因表达的变化。